Singapore markets closed

Straits Times Index
3,280.10
-7.65(-0.23%)
Nikkei
37,934.76
+306.28(+0.81%)
Hang Seng
17,651.15
+366.61(+2.12%)
FTSE 100
8,139.83
+60.97(+0.75%)
Bitcoin USD
63,190.32
-1,108.58(-1.72%)
CMC Crypto 200
1,312.97
-83.56(-5.99%)

Organon & Co. (OGN)

NYSE - NYSE Delayed price. Currency in USD

Add to watchlist

18.55

+0.13

(+0.71%)

At close: 04:00PM EDT

18.40

-0.15

(-0.81%)

After hours:

07:49PM EDT

Trade prices are not sourced from all markets

Press releases

Business Wire
Organon To Report First Quarter 2024 Results and Host Conference Call on May 2, 2024
JERSEY CITY, N.J., April 08, 2024--Organon To Report First Quarter 2024 Results and Host Conference Call on May 2, 2024
Business Wire
Phase 3 Comparative Clinical Study of Prolia® and Xgeva® (denosumab) Biosimilar Candidate HLX14 Met Primary Endpoints
SHANGHAI, China & JERSEY CITY, N.J., April 08, 2024--Organon and Henlius announce that Phase 3 Comparative Clinical Study of Prolia® and Xgeva® (denosumab) Biosimilar Candidate HLX14 Met Primary Endpoint
CNW Group
On International Women's Day, Organon Canada is encouraging businesses to Invest in HER and help address gender inequities through women's health
On International Women's Day, Organon Canada, a subsidiary of Organon (NYSE: OGN), a global healthcare company with a focus on women's health, launches HER Professional Journey and is encouraging businesses in Canada to Invest in HER and address the unique health experiences that women face, including in the workplace, so that women can feel supported and empowered at every stage of their career.